Tisagenlecleucel car-pos t
Full descriptor
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Details
- Code
- Q2042
- Short descriptor
- Tisagenlecleucel car-pos t
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2019
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Axicabtagene ciloleucel car+
Sipuleucel-t auto cd54+
Influenza virus vaccine, nos
Fluzone vacc, 3 yrs & >, im
Fluvirin vacc, 3 yrs & >, im
Flulaval vacc, 3 yrs & >, im
Imported lipodox inj
Afluria vacc, 3 yrs & >, im
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.